COPD: open trials in China

52 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07477600
cfMSC Stem Cell Therapy Targeting COPD
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT07725939
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Trial Treatment · Phase 2 · UCB Biopharma SRL
Copd01 20001, Beijing · Copd01 20004, Chengdu · Copd01 20006, Guangzhou · Copd01 20003, Hangzhou · Copd01 20005, Hangzhou · Copd01 20002, Nanchang · Copd01 20012, Shijiazhuang · Copd01 20015, Yangzhou SHI · Copd01 20007, Zhanjiang
Registry updated 2026-10-27
NCT07363694
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Trial Treatment · Phase 2/3 · Pfizer
China-Japan Friendship Hospital, Beijing · The Second Xiangya Hospital of Central South University, Changsha · The First Hospital of Changsha, Changsha · Chengdu Fifth People's Hospital, Chengdu · The People's Hospital of Chizhou, Chizhou · Chongqing Red Cross Hospital (Jiangbei District People's Hospital), Chongqing · Fuyang People's Hospital, Fuyang · The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou · Anhui Chest Hospital, Hefei · Inner Mongolia People's Hospital, Hohhot · The Affiliated Hospital of Inner Mongolia Medical University, Hohhot · Huizhou Central People's Hospital, Huizhou · Jinan Central Hospital, Jinan · Taizhou Hospital of Zhejiang Province, Linhai · Jiangxi Provincial People's Hospital, Nanchang · Zhongda Hospital Southeast University, Nanjing · Shanghai Tongji Hospital, Shanghai · Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai · The Central Hospital of Wuhan, Wuhan · The First People's Hospital of Xinxiang, Xinxiang · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · Yangzhou University Affiliated Hospital, Yangzhou
Registry updated 2026-10-22
NCT07701096
RESET-COPD Cohort: Real-Time Monitoring and Early Warning in COPD Patients Receiving Home NPPV
Research · Beijing Chao Yang Hospital
Beijing Chao-Yang Hospital, Capital Medical University, Beijing
Registry updated 2026-10-19
NCT07759245
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Trial Treatment · Phase 2 · Eli Lilly and Company
The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technolo -T, Baotou · China-Japan Friendship Hospital, Beijing · Sichuan Provincial People's Hospital, Chengdu · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · Jiangyin People's Hospital, Jiangyin · Jinan Central Hospital, Jinan · Pingxiang People's Hospital, Pingxiang · Shanghai General Hospital, Shanghai · Shenzhen People's Hospital, Shenzhen · Tianjin Medical University General Hospital, Tianjin · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The First People's Hospital of Xinxiang, Xinxiang
Registry updated 2026-10-08
NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Trial Treatment · Phase 3 · GlaxoSmithKline
GSK Investigational Site, Beijing · GSK Investigational Site, Changchun · GSK Investigational Site, Changsha · GSK Investigational Site, Chengdu · GSK Investigational Site, Chongqing · GSK Investigational Site, Dongguan · GSK Investigational Site, Fuyang · GSK Investigational Site, Guangzhou · GSK Investigational Site, Guilin · GSK Investigational Site, Haikou · GSK Investigational Site, Hangzhou · GSK Investigational Site, Hefei · GSK Investigational Site, Hohhot · GSK Investigational Site, Huizhou · GSK Investigational Site, Jiangmen · GSK Investigational Site, Jiangsu · GSK Investigational Site, Jiangxi · GSK Investigational Site, Jinan · GSK Investigational Site, Kunming · GSK Investigational Site, Lianyungang · GSK Investigational Site, Liuzhou · GSK Investigational Site, Meizhou · GSK Investigational Site, Mianyang · GSK Investigational Site, Nanchang · GSK Investigational Site, Qingdao · GSK Investigational Site, Qingyuan · GSK Investigational Site, Qinhuangdao · GSK Investigational Site, Shanghai · GSK Investigational Site, Suzhou · GSK Investigational Site, Taiyuan · GSK Investigational Site, Taizhou · GSK Investigational Site, Ürümqi · GSK Investigational Site, Weifang · GSK Investigational Site, Wenzhou · GSK Investigational Site, Wuhan · GSK Investigational Site, Wuxi · GSK Investigational Site, Xiamen · GSK Investigational Site, Xi'an · GSK Investigational Site, Yinchuan · GSK Investigational Site, Zhanjiang · GSK Investigational Site, Zhengzhou · GSK Investigational Site, Zigong
Registry updated 2026-10-05
NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Trial Treatment · Phase 3 · AstraZeneca
Research Site, Anning · Research Site, Anyang · Research Site, Baotou · Research Site, Beijing · Research Site, Changsha · Research Site, Changzhi · Research Site, Chengdu · Research Site, Chifeng · Research Site, Chizhou · Research Site, Chongqing · Research Site, Daqing · Research Site, Dazhou · Research Site, Foshan · Research Site, Fuzhou · Research Site, Guangzhou · Research Site, Haikou · Research Site, Hangzhou · Research Site, Hefei · Research Site, Heze · Research Site, Hohhot · Research Site, Huizhou · Research Site, Jiaozuo · Research Site, Jinhua · Research Site, Jining · Research Site, Kaifeng · Research Site, Langfang · Research Site, Lanzhou · Research Site, Lishui · Research Site, Liuzhou · Research Site, Nanchang · Research Site, Nanjing · Research Site, Nanyang · Research Site, Pingxiang · Research Site, Qingdao · Research Site, Qingyuan · Research Site, Ruian · Research Site, Sanya · Research Site, Shanghai · Research Site, Shantou · Research Site, Shaoxing · Research Site, Shenyang · Research Site, Shenzhen · Research Site, Shihezi · Research Site, Shijiazhuang · Research Site, Siping · Research Site, Suining Shi · Research Site, Taicang · Research Site, Taiyuan · Research Site, Taizhou · Research Site, Ürümqi · Research Site, Weifang · Research Site, Wenzhou · Research Site, Xiamen · Research Site, Xi'an · Research Site, Xiangtan · Research Site, Xianyang · Research Site, Xingtai · Research Site, Xinxiang · Research Site, Xuzhou · Research Site, Yangzhou · Research Site, Yinchuan · Research Site, Zaozhuang · Research Site, Zhangzhou · Research Site, Zhengzhou · Research Site, Zhuhai · Research Site, Zhumadian · Research Site, Zhuzhou · Research Site, Zigong
Registry updated 2026-10-02
NCT05799664
Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD
Trial Treatment · Hangzhou Broncus Medical Co., Ltd.
West China Hospital of Sichuan University, Chengdu
Registry updated 2026-09-30
NCT07828353
A Clinical Study of REGEND001 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Trial Treatment · Phase 3 · Regend Therapeutics
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Registry updated 2026-09-24
NCT07382986
IMPACT COPD Cohort (China)
Research · Beijing Chao Yang Hospital
Hebi Coal Industry Group General Hospital, Hebi · Mianyang third people's hospital, Mianyang · The First Affiliated Hospital of Shihezi University, Shihezi · Tongliao Second People's Hospital, Tongliao
Registry updated 2026-09-21
NCT07823842
T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPD
Research · Shanghai Pulmonary Hospital, Shanghai, China
Shanghai Pulmonary Hospital, Shanghai
Registry updated 2026-09-16
NCT07402551
Phase II Study of RC1416 Injection in COPD
Trial Treatment · Phase 2 · Nanjing RegeneCore Biotech Co., Ltd.
Anyang People's Hospital, Anyang · The Second Hospital of Jilin University, Changchun · The Third People's Hospital of Chengdu City, Chengdu · The First People's Hospital of Shuangliu District, Chengdu, Chengdu · Chengdu Fifth People's Hospital, Chengdu · The Affiliated Bishan Hospital of Chongqing Medical University, Chongqing · Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing · The First Affiliated Hospital of Jinan University, Guangzhou · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · The First People's Hospital of Hangzhou (Westlake University Affiliated The First People's Hospital of Hangzhou), Hangzhou · Anhui Provincial Chest Hospital, Hefei · The Affiliated Hospital of Inner Mongolia Medical University, Hohhot · Huizhou Third People's Hospital, Huizhou · Jiangmen Central Hospital, Jiangmen · Jiaozuo Second People's Hospital, Jiaozuo · Jiu Jiang NO.1 People's Hospital, Jiujiang · The First People's Hospital of Lianyungang City, Lianyungang · Liaocheng People's Hospital, Liaocheng · Loudi Central Hospital, Loudi · Mianyang Central Hospital, Mianyang · Nanjing First Hospital, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · Nanyang First People's Hospital, Nanyang · Nanyang Second People's Hospital, Nanyang · People's Hospital of Pingxiang City, Pingxiang · QingDao Municipal Hospital, Qingdao · Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Qingyuan · Sanmenxia Central Hospital, Sanmenxia · Shanghai Pulmonary Hospital, Shanghai · Shengjing Hospital Of China Medical University, Shenyang · Suining Central Hospital, Suining · Wan Bei General Hospital of Wanbei Coal power Group, Suzhou · The Second People's Hospital of Weifang, Weifang · The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU, Wenzhou · Zhongshan Hospital Xiamen University, Xiamen · Xinxiang First People's Hospital, Xinxiang · Suining County People's Hospital, Xuzhou · Xuzhou Central Hospital, Xuzhou · Yangzhou University Affiliated Hospital, Yangzhou · Yichang Central People's Hospital, Yichang · The First people's hospital of Yulin, Yulin · Zaozhuang Municipal Hospital, Zaozhuang · Zibo Municipal Hospital, Zibo · Zigong First People's Hospital Zigong Academy of Medicalsciences, Zigong · Affiliated Hospital of Zunyi Medical University, Zunyi
Registry updated 2026-09-08
NCT06883305
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Trial Treatment · Phase 3 · AstraZeneca
Research Site, Anyang · Research Site, Beijing · Research Site, Changchun · Research Site, Changsha · Research Site, Chengdu · Research Site, Chongqing · Research Site, Fuzhou · Research Site, Guangzhou · Research Site, Haikou · Research Site, Hangzhou · Research Site, Hefei · Research Site, Hengyang · Research Site, Heze · Research Site, Hohhot · Research Site, Huizhou · Research Site, Jinan · Research Site, Jinhua · Research Site, Linhai · Research Site, Loudi · Research Site, Nanchang · Research Site, Nanchong · Research Site, Nanjing · Research Site, Nanning · Research Site, Pingxiang · Research Site, Qingdao · Research Site, Qingyuan · Research Site, Sanya · Research Site, Shanghai · Research Site, Shantou · Research Site, Shenyang · Research Site, Shenzhen · Research Site, Shijiazhuang · Research Site, Suining Shi · Research Site, Taiyuan · Research Site, Taizhou · Research Site, Tianjin · Research Site, Wenzhou · Research Site, Wuhan · Research Site, Xinxiang · Research Site, Xuzhou · Research Site, Yangzhou · Research Site, Yichang · Research Site, Yinchuan · Research Site, Zhangzhou
Registry updated 2026-09-03
NCT07780682
TCM Cohort for Elderly COPD
Research · Henan University of Traditional Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou
Registry updated 2026-08-21
NCT07640451
A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Trial Treatment · Phase 2 · Guangdong Hengrui Pharmaceutical Co., Ltd
Shanghai Tongji Hospital, Shanghai
Registry updated 2026-08-18
NCT07762573
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study
Research · Nanfang Hospital, Southern Medical University
Nanfang Hospital, Southern Medical University, Guangzhou
Registry updated 2026-08-13
NCT07751003
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
Trial Treatment · Sir Run Run Shaw Hospital
The Second Xiangya Hospital of Central South University, Changsha · Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou · Taizhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenling · Henan Provincial People's Hospital, Zhengzhou
Registry updated 2026-08-06
NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Trial Treatment · Phase 3 · GlaxoSmithKline
GSK Investigational Site, Beijing · GSK Investigational Site, Changchun · GSK Investigational Site, Changsha · GSK Investigational Site, Chengdu · GSK Investigational Site, Chongqing · GSK Investigational Site, Dongguan · GSK Investigational Site, Fujian · GSK Investigational Site, Guangzhou · GSK Investigational Site, Guilin · GSK Investigational Site, Haikou · GSK Investigational Site, Hangzhou · GSK Investigational Site, Harbin · GSK Investigational Site, Hefei · GSK Investigational Site, Hohhot · GSK Investigational Site, Huizhou · GSK Investigational Site, Jiangmen · GSK Investigational Site, Jinzhou · GSK Investigational Site, Nanchang · GSK Investigational Site, Nanjing · GSK Investigational Site, Nanning · GSK Investigational Site, Qinhuangdao · GSK Investigational Site, Shanghai · GSK Investigational Site, Shapingba · GSK Investigational Site, Shijiazhuang · GSK Investigational Site, Suining · GSK Investigational Site, Taiyuan · GSK Investigational Site, Taizhou · GSK Investigational Site, Ürümqi · GSK Investigational Site, Weifang · GSK Investigational Site, Wenzhou · GSK Investigational Site, Xiamen · GSK Investigational Site, Xinxiang · GSK Investigational Site, Yinchuan · GSK Investigational Site, Zunyi
Registry updated 2026-07-28
NCT06958666
Effectiveness of DITM Versus IMT in COPD Patients
Trial Treatment · Sir Run Run Shaw Hospital
Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Jinyun County Hospital of Traditional Chinese Medicine, Lishui · Zhejiang Xianju County People's Hospital, Taizhou · Department of Respiratory and Critical Care Medicine, Linhai Second People's Hospital, 198 Dubei Road, Duqiao Town, Taizhou · Taizhou Hospital of Zhejiang Province, Taizhou · Taizhou Integrated Traditional Chinese and Western Medicine Hospital, Taizhou · Department of Respiratory Care, Taizhou Central Hospital, Taizhou · Department of Respiratory and Critical Care Medicine Wenling First People's Hospital, Taizhou
Registry updated 2026-07-24
NCT07567872
A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD
Trial Treatment · Phase 1 · Guangdong Hengrui Pharmaceutical Co., Ltd
West China Hospital，Sichuan University, Chengdu
Registry updated 2026-07-20
NCT07097896
Endobronchial Silicone Valve for Patients With Emphysema
Trial Treatment · China-Japan Friendship Hospital
China-Japan Friendship Hospital, Beijing
Registry updated 2026-07-08
NCT07030881
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy
Trial Treatment · First Affiliated Hospital of Ningbo University
The Second Affiliated Hospital of Harbin Medical University, Harbin · Anhui Chest Hospital, Hefei · The Second Affiliated Hospital Of Anhui Medical University, Hefei · Ningbo Medical Center Lihuili Hospital, Ningbo · The First Affiliated Hospital of Ningbo University, Ningbo · Beilun District Second People's Hospital, Ningbo · Ninghai County First Hospital, Ninghai · Taizhou Municipal Hospital, Taizhou · Taizhou Central Hospital, Taizhou
Registry updated 2026-06-26
NCT07665359
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
Trial Treatment · Second Affiliated Hospital, Zhejiang University, School of Medicine
West China Hospital, Chengdu · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · Sir Run Run Shaw Hospital, Hangzhou · Red Cross Hospital, Hangzhou, China, Hangzhou · Zhejiang Hospital, Hangzhou · First Affiliated Hospital of Zhejiang University, Hangzhou · Huzhou Central Hospital, Huzhou · Zhejiang Rongjun Hospital, Jiaxing · Affiliated Hospital of Jiaxing University, Jiaxing · The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui · Lishui hospital of Zhejiang University, Lishui · Second Affiliated Hospital of Nanchang University, Nanchang · Zhejiang Quhua Hospital, Quzhou · Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai · Shanghai Pulmonary Hospital, Shanghai. China, Shanghai · Shaoxing People's Hospital, Shaoxing · Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou · Taizhou Hospital, Taizhou · First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Tongji Hospital, Wuhan
Registry updated 2026-06-24
NCT07658339
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD
Trial Treatment · Phase 3 · Haisco Pharmaceutical Group Co., Ltd.
Peking University Third Hospital, Beijing
Registry updated 2026-06-22
NCT07583849
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
Trial Treatment · Phase 3 · Haisco Pharmaceutical Group Co., Ltd.
Peking University People's Hospital, Beijing
Registry updated 2026-06-10

All COPD trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error